Protein-Polydimethylsiloxane Particles in Liquid Vial Monoclonal Antibody Formulations Containing Poloxamer 188.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2020.03.010
Abstract: Surfactants play an important role in stabilizing proteins in liquid formulations against aggregate/particle formation during processing, handling, storage, and transportation. Only three surfactants are currently used in marketed therapeutic protein formulations: polysorbate 20, polysorbate 80,… read more here.
Keywords: antibody formulations; poloxamer; protein polydimethylsiloxane; poloxamer 188 ... See more keywords